S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
NYSE:REED

Reed's (REED) Stock Price, News & Analysis

$1.83
-0.06 (-3.17%)
(As of 04/19/2024 ET)
Today's Range
$1.83
$1.88
50-Day Range
$1.53
$2.28
52-Week Range
$1.35
$3.75
Volume
882 shs
Average Volume
3,581 shs
Market Capitalization
$7.63 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$7.00

Reed's MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
282.5% Upside
$7.00 Price Target
Short Interest
N/A
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
-0.04mentions of Reed
Based on 15 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($1.06) to ($0.74) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.84 out of 5 stars

REED stock logo

About Reed's Stock (NYSE:REED)

Reed's, Inc. engages in the manufacture and distribution of natural beverages in the United States. The company offers Reed's craft ginger beer; Reed's real ginger ales; Reed's Mules; Reed's Hard Ginger Ale; Reed's ready to drink products; and Virgil's handcrafted sodas. It sells its products to natural food and gourmet retailers, grocery store chains, mass merchants, club stores, convenience and drug stores, liquor stores, industrial cafeterias, and on-premise bars and restaurants, as well as directly to consumers through www.drinkreeds.com. The company was formerly known as Original Beverage Corporation and changed its name to Reed's, Inc. in 2001. Reed's, Inc. was founded in 1987 and is headquartered in Norwalk, Connecticut.

REED Stock Price History

REED Stock News Headlines

Reed’s Surprise Mock Draft
StockNews.com Initiates Coverage on Reed's (NYSE:REED)
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
See More Headlines
Receive REED Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Reed's and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
6/01/2023
Today
4/19/2024
Next Earnings (Estimated)
5/30/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Bottled & canned soft drinks
Sub-Industry
N/A
Employees
22
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$7.00
High Stock Price Target
$7.00
Low Stock Price Target
$7.00
Potential Upside/Downside
+270.2%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$-15,520,000.00
Pretax Margin
-34.72%

Debt

Sales & Book Value

Annual Sales
$44.71 million
Book Value
($4.62) per share

Miscellaneous

Free Float
2,222,000
Market Cap
$7.89 million
Optionable
Not Optionable
Beta
1.14
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Key Executives

  • Mr. Norman E. Snyder Jr. (Age 63)
    CEO & Director
    Comp: $376.22k
  • Mr. Christopher J. Reed (Age 66)
    Founder
    Comp: $141.88k
  • Ms. Joann Christine Tinnelly (Age 54)
    CFO & Secretary
  • Mr. Damian Warshall
    Vice President of Operations
  • Mr. Philip T. Trotman
    Director of Marketing
  • Mr. Christopher Burleson (Age 42)
    Chief Commercial Officer

REED Stock Analysis - Frequently Asked Questions

Should I buy or sell Reed's stock right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Reed's in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" REED shares.
View REED analyst ratings
or view top-rated stocks.

What is Reed's' stock price target for 2024?

1 equities research analysts have issued 12-month price targets for Reed's' shares. Their REED share price targets range from $7.00 to $7.00. On average, they predict the company's share price to reach $7.00 in the next year. This suggests a possible upside of 282.5% from the stock's current price.
View analysts price targets for REED
or view top-rated stocks among Wall Street analysts.

How have REED shares performed in 2024?

Reed's' stock was trading at $1.60 at the beginning of the year. Since then, REED shares have increased by 14.4% and is now trading at $1.83.
View the best growth stocks for 2024 here
.

When is Reed's' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 30th 2024.
View our REED earnings forecast
.

How were Reed's' earnings last quarter?

Reed's, Inc. (NYSE:REED) announced its quarterly earnings data on Thursday, June, 1st. The company reported ($1.70) EPS for the quarter, missing the consensus estimate of ($1.02) by $0.68. The firm had revenue of $11.16 million for the quarter, compared to analysts' expectations of $14.12 million.

How do I buy shares of Reed's?

Shares of REED stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:REED) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners